NYSE · PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS · LARGE CAP
Edgewell Personal Care Company EPC
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.2B
▼ 1.3% vs FY2024
EPS · FY25
$0.53
Dividend / sh · FY25
—
Payout · FY25
115%
ROE · FY25
1.6%
Net margin · FY25
1.1%
Dividend coverage
-3.0×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.2B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
1 cents of every revenue dollar became profit this year.
Per share
USD 0.53
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
1.6%
Return on equity, FY2025
ROE
Operating margin4.3%
Net margin1.1%
Return on assets0.7%
Each USD of equity produced 2 cents of profit this year.
Returned to shareholders
USD 119.5M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 29.3M
Net buybacksUSD 90.2M
Share of profit470.5%
Consecutive raises—
USD 29.3M in dividends and USD 90.2M in buybacks — 470% of the year's profit, so the payout drew on cash built up earlier.
Growth
+2.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+0.8%
+2.7%
−0.8%
−4.2%
Net income
−36.6%
−17.8%
−16.8%
EPS, diluted
−34.1%
−15.6%
−14.7%
Returned to shareholders
−8.9%
−7.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.05B
Shares outstanding, FY2025
Change, 5 years−14.5%
Change, 10 years−22.8%
The share count shrank 15% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 3.8B
total assets, end of FY2025
Total assetsUSD 3.8B
EquityUSD 1.6B
CashUSD 225.7M
Gross debtUSD 1.4B
Net debtUSD 1.2B
Current ratio1.76×
Net debt stands at 75% of equity.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
2.2
2.3
2.3
2.2
2.1
1.9
2.1
2.2
2.3
2.4
2.4
2.6
2.4
4.6
4.6
4.2
4.0
4.3
Operating income $B
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
−0.1
0.2
−0.5
·
·
·
·
·
·
·
EBITDA $B
0.2
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.0
0.3
−0.3
·
·
·
·
·
·
·
Income tax $B
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.1
−0.1
0.0
−0.2
0.0
0.1
0.2
0.1
0.1
0.1
0.1
Net income $B
0.0
0.1
0.1
0.1
0.1
0.1
−0.4
0.1
0.0
0.2
−0.3
0.4
0.4
0.4
0.3
0.4
0.3
0.3
EPS, diluted $
0.53
1.97
2.21
1.85
2.13
1.24
−6.88
1.90
0.10
2.99
−4.44
5.69
6.47
6.22
3.72
5.72
4.72
5.59
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
1.50
2.00
1.70
·
·
·
·
·
Payout %
115
31
27
33
22
0
−0
·
0
0
−34
35
26
6
0
0
·
·
ROE %
1.6
6.3
7.6
6.5
7.8
4.9
−24.4
5.9
0.3
9.7
−12.6
14.3
18.0
19.6
12.4
20.9
21.6
33.1
Shares out B
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.06
0.06
0.06
0.06
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
69 of 69
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed